Javascript must be enabled to continue!
Creation and Evaluation of New Growth Charts With a Gradual Transition From WHO to CDC Values
View through CrossRef
BACKGROUND AND OBJECTIVES
At age 2 years, the Centers for Disease Control and Prevention (CDC) recommends switching from the World Health Organization (WHO) Growth Standards to the CDC 2000 Growth Reference. This abrupt switch may affect growth assessment, such as causing a clinically important change in growth z score in a child with a stable growth pattern. We sought to create growth charts that gradually transition between WHO and CDC and to evaluate their impact on growth assessment of young children using real-world data.
METHODS
We iteratively developed methods to create new charts for body mass index (BMI)-, weight-, and length/height-for-age. We performed a retrospective cohort study comparing the mean change in z scores for these parameters between 1.5 and 2 years for the CDC-recommended vs the new, gradually transitioned (gradual) charts. We also compared the prevalence of a large change in z score: <−1 (drop) or >1 (rise).
RESULTS
We transitioned between the charts using a weighted average from ages 2 to 5 years. In 7429 children, there was a large decrease in mean body mass index-for-age z score (BMIz) and weight-for-age z score (WTz) in the CDC-recommended charts (BMIz −0.59, WTz −0.35) that was not seen in the gradual charts (BMIz −0.09, WTz −0.01). Correspondingly, using the CDC-recommended charts, the proportion with a drop in BMIz or WTz was much higher for the CDC-recommended (BMIz 28.3%, WTz 6.0%) than the gradual charts (BMIz 11.6%, WTz 0.85%).
CONCLUSIONS
We created growth charts that gradually transition between WHO and CDC and may reduce overidentification of slow weight gain. These charts may be useful in clinical care and research.
American Academy of Pediatrics (AAP)
Title: Creation and Evaluation of New Growth Charts With a Gradual Transition From WHO to CDC Values
Description:
BACKGROUND AND OBJECTIVES
At age 2 years, the Centers for Disease Control and Prevention (CDC) recommends switching from the World Health Organization (WHO) Growth Standards to the CDC 2000 Growth Reference.
This abrupt switch may affect growth assessment, such as causing a clinically important change in growth z score in a child with a stable growth pattern.
We sought to create growth charts that gradually transition between WHO and CDC and to evaluate their impact on growth assessment of young children using real-world data.
METHODS
We iteratively developed methods to create new charts for body mass index (BMI)-, weight-, and length/height-for-age.
We performed a retrospective cohort study comparing the mean change in z scores for these parameters between 1.
5 and 2 years for the CDC-recommended vs the new, gradually transitioned (gradual) charts.
We also compared the prevalence of a large change in z score: <−1 (drop) or >1 (rise).
RESULTS
We transitioned between the charts using a weighted average from ages 2 to 5 years.
In 7429 children, there was a large decrease in mean body mass index-for-age z score (BMIz) and weight-for-age z score (WTz) in the CDC-recommended charts (BMIz −0.
59, WTz −0.
35) that was not seen in the gradual charts (BMIz −0.
09, WTz −0.
01).
Correspondingly, using the CDC-recommended charts, the proportion with a drop in BMIz or WTz was much higher for the CDC-recommended (BMIz 28.
3%, WTz 6.
0%) than the gradual charts (BMIz 11.
6%, WTz 0.
85%).
CONCLUSIONS
We created growth charts that gradually transition between WHO and CDC and may reduce overidentification of slow weight gain.
These charts may be useful in clinical care and research.
Related Results
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
BACKGROUND
Suicide is a complex, serious and multifaceted public health issue that poses significant challenges to societies worldwide. In fact, it represen...
Re-Examining Growth Charts for U.S. Children Aged 5 Through 11 Using Data from 2010 to 2016
Re-Examining Growth Charts for U.S. Children Aged 5 Through 11 Using Data from 2010 to 2016
Purpose: The present study seeks to compare growth charts for U.S. children’s height, weight, and BMI using recent data from 2010-2016 to the 2000 CDC growth charts.<br><b...
How to Co-Create: A Compendium of Methods for Co-Creating Solutions to Complex and Wicked Problems in Public Health
How to Co-Create: A Compendium of Methods for Co-Creating Solutions to Complex and Wicked Problems in Public Health
Background: Co-creation has become a vital approach in public health, engaging diverse stakeholders, including vulnerable and marginalized populations, to collaboratively design an...
Extrauterine growth restriction in very low birth weight infants according to different growth charts: a retrospective 10 years observational study
Extrauterine growth restriction in very low birth weight infants according to different growth charts: a retrospective 10 years observational study
Abstract
Background
Extrauterine growth restriction (EUGR) is common among very low birth weight (VLBW) infants and associated with poor neurodevelopmental outcomes. Preva...
Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).
Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).
Abstract
Assessment of chimerism after AHSCT has been important to monitor donor hematopoietic engraftment and to assess for residual disease or relapse. Achievement...
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Abstract
The rapid growth of open access publishing (OAP) has significantly improved the accessibility and dissemination of scientific knowledge. However, this expansion has also c...
Exploring Sources of Inaccuracy and Irreproducibility in the CDC Bottle Bioassay Through Direct Insecticide Quantification
Exploring Sources of Inaccuracy and Irreproducibility in the CDC Bottle Bioassay Through Direct Insecticide Quantification
Abstract
Background The Centers for Disease Control and Prevention (CDC) bottle bioassay is a commonly used susceptibility test for measuring insect response to insecticide...
Comparison of Changes in Growth Percentiles of US Children on CDC 2000 Growth Charts With Corresponding Changes on WHO 2006 Growth Charts
Comparison of Changes in Growth Percentiles of US Children on CDC 2000 Growth Charts With Corresponding Changes on WHO 2006 Growth Charts
Longitudinal data with 37 964 length and weight measurements from 10 844 children who participated in the California Child Health and Development Study was used to compare the prop...

